Browse Articles
Discover research articles across all indexed journals
Health literacy and environmental health behaviors in the context of microplastic exposure: a cross-sectional study in rural Thailand
Abstract Microplastic contamination has emerged as a growing environmental exposure concern in river-dependent rural populations, yet evidence on behavioral determinants remains limited. Health literacy is a key upstream determinant that may influence risk perception and preventive behavioral responses. This study examined the association between health literacy and preventive behaviors related to microplastic exposure among residents living along the Mun River in Buriram Province, Thailand. A community-based cross-sectional study was conducted among 268 adults selected using multistage sampling. Data were collected through structured interviewer-administered questionnaires. Health literacy was operationalized as a multidimensional construct covering six domains and categorized into sufficient and insufficient levels. Preventive behaviors were dichotomized as good or poor based on predefined scoring criteria. Multivariable logistic regression models were applied to estimate adjusted associations between health literacy and preventive behaviors while controlling for potential confounders, including sociodemographic and behavioral factors. Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were reported. Insufficient health literacy was highly prevalent (70.9%) and was independently associated with poor preventive behaviors (AOR = 6.05, 95% CI: 3.08–11.90, p < 0.001) after adjustment for covariates. Domain-specific analysis identified action literacy (AOR = 2.67, 95% CI: 1.29–5.59, p = 0.008) and appraisal literacy (AOR = 3.19, 95% CI: 1.51–6.73, p = 0.002) as significant predictors. Frequent fish consumption was also independently associated with poor preventive behaviors (AOR = 3.25, 95% CI: 1.35–7.84, p = 0.009). Health literacy is a strong independent correlate of preventive behaviors related to microplastic exposure in rural riverine populations. Findings support targeted, domain-specific health literacy interventions—particularly action- and appraisal-oriented competencies—as a public health strategy to reduce environmental exposure risk.
Dexime: A Selectively Enzyme‐Degradable Hydrogel for Protein Therapeutic Release
ABSTRACT Hydrogels are of great interest for the delivery of protein therapeutics as they obviate the denaturing shear forces and/or organic solvents common to other delivery systems. Dextrin, a polysaccharide derived from starch, has been largely ignored in the design of hydrogels, yet is biodegradable and can be modified to allow in situ gelation after injection by click‐crosslinking. Herein, dextrin is modified with either ketone or aldehyde moieties and then click‐crosslinked with poly(ethylene glycol)‐tetraoxyamine to form dextrin‐oxime (dexime) hydrogels. The rheological and mechanical properties are tunable by changing formulation parameters such as total dextrin weight percentage (wt.%) and pH. The hydrogels are injectable through a 30G needle, selectively degradable via α‐amylase, yet stable and minimally swelling in the presence of other enzymes, including hyaluronidase and chondroitinase ABC (ChASE). The presence of low amounts of α‐amylase in many fluids and tissues of the body allow for the slow degradation of dexime with minimal swelling. Dexime is particularly useful for local delivery of ChASE: an enzyme that degrades the aggregate scar formed after injury in the central nervous system. Dexime is cytocompatible and releases active ChASE both in vitro and in vivo as evidenced by chondroitin sulphate proteoglycan degradation in the spinal cord.
Comparative real-world outcomes of durvalumab plus gemcitabine/cisplatin versus pembrolizumab plus gemcitabine/cisplatin as first-line therapy for advanced biliary tract cancer.
133 Background: Durvalumab plus gemcitabine/cisplatin (D+GC; TOPAZ-1) and pembrolizumab plus gemcitabine/cisplatin (P+GC; KEYNOTE-966) are both NCCN Category 1 preferred first-line regimens for advanced biliary tract cancer (BTC). No randomized head-to-head trial comparing these two chemoimmunotherapy regimens exists, and real-world comparative data remain limited. We compared survival and safety outcomes between D+GC and P+GC using a large federated electronic health records network. Methods: Using the TriNetX Global Collaborative Network, we identified adults with BTC (ICD-10: C22.1, C24.0, C23, C24.1) who received durvalumab or pembrolizumab as index therapy with gemcitabine/cisplatin within 30 days. 1:1 PSM balanced cohorts on age, sex, race/ethnicity, BTC subtype, modified Charlson comorbidities, and baseline labs (albumin, bilirubin, CA 19-9, creatinine, hemoglobin). OS was assessed by Kaplan-Meier analysis with log-rank testing. Safety was evaluated as risk of adverse events after index. Results: Before PSM, 3,220 received D+GC and 317 received P+GC; after matching, 246 remained per arm. Median follow-up was 270 days (D+GC) and 204 days (P+GC). Outcomes are shown in Table 1. Conclusions: In this PSM real-world analysis, D+GC and P+GC demonstrated comparable OS as first-line therapy for advanced BTC. P+GC was associated with significantly lower rates of thrombocytopenia, anemia, renal injury, and hospitalizations. These findings suggest a potentially favorable tolerability profile with P+GC that may inform treatment selection. Prospective comparative studies are warranted. Outcome D+GC (n=246) P+GC (n=246) HR/OR (95% CI) P value Median OS, days 461 377 HR 1.15 (0.88–1.52) 0.305 Mortality risk 42.8% 41.8% OR 0.96 (0.67–1.38) 0.824 Thrombocytopenia 35.5% 22.8% OR 0.54 (0.35–0.81) 0.003 Anemia 48.0% 35.2% OR 0.59 (0.38–0.91) 0.017 Renal injury 29.6% 17.8% OR 0.51 (0.32–0.81) 0.004 Hospitalization 47.7% 30.7% OR 0.49 (0.25–0.93) 0.028 Nausea/vomiting 33.1% 23.9% OR 0.63 (0.38–1.05) 0.073 Neutropenia 16.2% 16.3% OR 1.01 (0.61–1.66) 0.972 Rash 7.7% 7.2% OR 0.92 (0.45–1.90) 0.828 Hypothyroidism 7.8% 5.7% OR 0.72 (0.34–1.56) 0.406 HR/OR reported as P+GC vs D+GC. HR >1 indicates higher hazard with P+GC.
Total Synthesis of Allocyclinone A via Late‐Stage Halogen Swapping
ABSTRACT Allocyclinones A–D are small congeners of angucyclinones with several unusual structural features and potent antibiotic activity against various Gram‐positive pathogens. Allocyclinone A, the most active congener, contains an intriguing aromatic trichloromethyl substituent that has never been observed in other natural products before. In this study, we report a modular total synthesis of allocyclinones A and B featuring the convergent assembly of three key building blocks through Hauser annulation and cross‐couplings. The synthesis of allocyclinone A was made possible by the application of a late‐stage trifluoromethyl‐to‐trichloromethyl swap, providing a potentially generalizable strategy for aromatic trichloromethyl installation in complex settings. The antibiotic activity of the scaffold was also verified, and attempts to elucidate its mode of action were performed.
Assessment of anti-VEGF intravitreal injection effects on murine neonatal Schlemm’s canal morphology
Chiral Memory‐Driven Helical Supramolecular Photodetector for Deciphering Circularly Polarized Light
ABSTRACT Chiral π‐conjugated organic small molecules, due to their intrinsic chirality, well‐defined molecular structures and ease of modification, are promising for circularly polarized light (CPL) detection. However, their practical application is hindered by low absorption dissymmetry factor ( g abs ), arising from imbalanced electric and magnetic transition dipole moments ( µ and m ). Here, a template‐free method using chiral memory effect was reported to fabricate helical supramolecules with high g abs . Two chiral dinaphthocoronene tetraimides enantiomer pairs were synthesized: ( R )‐PDI‐( R )‐NI‐Ph/( S )‐PDI‐( S )‐NI‐Ph and ( S )‐PDI‐( R )‐NI‐Ph/( R )‐PDI‐( S )‐NI‐Ph. After annealing films at 350°C to remove chiral pendants, ( R )‐PDI‐( R )‐NI/( S )‐PDI‐( S )‐NI films showed much higher | g abs | (0.08) than the other set (0.01), with helical assemblies formed via chiral memory effect. Notably, large‐area arrays of ( R )‐PDI‐( R )‐NI films enabled CPL imaging, and a bionic artificial visual system was constructed with this film as “retina” and an artificial neural network as “neural center” for reliable CPL discrimination, offering a scalable strategy for high‐performance chiral optoelectronics.
Pathological complete response after neoadjuvant chemoimmunotherapy with toripalimab or camrelizumab in esophageal squamous cell carcinoma: A systematic review and meta-analysis.
109 Background: Neoadjuvant chemoimmunotherapy has reshaped the treatment paradigm for esophageal squamous cell carcinoma (ESCC), yet the relative efficacy of individual PD-1 inhibitors remains undefined. Pathological complete response (pCR) is a validated surrogate for long-term survival in ESCC. We performed a systematic review and indirect comparative synthesis to evaluate pCR outcomes between toripalimab and camrelizumab based neoadjuvant regimens. Methods: A systematic literature search of PubMed and Google Scholar was performed for studies published from January 2021 through January 2026. Identified prospective and observational studies evaluating toripalimab or camrelizumab combined with platinum-based chemotherapy in resectable ESCC. Dual independent screening and extraction were performed. Study quality was assessed using the Newcastle–Ottawa Scale and Jadad score. Case reports and animal studies were excluded. Pooled pCR event rates were calculated using random-effects modeling. Indirect comparisons were interpreted descriptively. Results: Thirteen studies comprising 916 patients were included: 3 randomized controlled trials, 4 single-arm trials, 1 cohort study, and 5 observational studies. Five studies evaluated toripalimab-based regimens (n = 461) and eight evaluated camrelizumab-based regimens (n = 6 72). In single-arm neoadjuvant chemoimmunotherapy studies, pooled pCR was 35% for camrelizumab (RD 0.35, 95% CI 0.30–0.40, I²=39%; 8 studies, n=672) and 30% for toripalimab (RD 0.30, 95% CI 0.26–0.35, I²=0%; 5 studies, n=461). These pooled estimates represent event rates and should be interpreted as an indirect comparison. Conclusions: Neoadjuvant chemoimmunotherapy incorporating camrelizumab demonstrated a numerically higher pooled pathological complete response rate than toripalimab in resectable ESCC (35% vs 30%); however, these findings derive from indirect cross-trial comparisons and remain vulnerable to heterogeneity in staging, chemotherapy backbone, surgical selection, and pCR assessment. Prospective head-to-head randomized trials with survival endpoints are required to determine whether this pCR signal translates into meaningful improvements in disease-free and overall survival.
Dual‐Channel Interdigitated Aptamer‐Based Sensors for Rapid Small‐Molecule Detection in Biofluids
ABSTRACT Timely and decentralized quantification of small‐molecule biomarkers is essential for point‐of‐care (POC) diagnostics, but their reliable detection in biofluids remains challenging. Here, we introduce an engineered electrochemical aptamer sensing platform that employs a dual‐channel signal conversion strategy to overcome these limitations. By integrating spatially separated interdigitated working electrodes with selective self‐assembled monolayer (SAM) removal, the system enables target‐induced release and recapture of methylene blue‐labeled complementary DNA (MB‐cDNA) probes across two electrodes. This configuration minimizes background interference and enhances mass transport, facilitating robust dual‐channel signal transduction. The platform enables rapid (≤ 30 min), low‐volume (30 µL) detection of prototypical small molecules, dopamine and cortisol, in diverse biofluids, including artificial cerebrospinal fluid (aCSF), human serum, and saliva. Notably, the signal conversion mechanism remained effective across different targets and sample types, requiring only minimal adaptation of the recognition sequence. Together, these features establish a versatile electrochemical sensing architecture with broad potential for rapid, quantitative small‐molecule analysis in complex biological media.
Chaos-driven design of highly nonlinear S-boxes for secure and efficient lightweight image encryption
Immunoengineering External Field Responsive Biomaterials for Tissue Repair and Regeneration
ABSTRACT Tissue defect repair is a dynamic process involving inflammation regulation, angiogenesis, organized extracellular matrix assembly, and immune microenvironment homeostasis. Its success critically depends on repair strategies with precise spatiotemporal control. External field‐responsive biomaterials (EFRBs), which respond to optical, magnetic, electrical, ultrasonic, and thermal stimuli, have become a research focus in regenerative medicine due to their on‐demand activation, unique (bio)physicochemical properties, and ability to modulate immune‐related pathways. This review first outlines the dynamic biological requirements of tissue repair, including the immune microenvironment's role, and the core advantages of EFRBs. It then details the structural features and external field response mechanisms of various EFRBs—such as nanoparticles, scaffolds, hydrogels, and microneedles—and their regulatory effects on immune‐related repair processes. Finally, it systematically summarizes recent advances in immunoengineering EFRBs for enhancing tissue repair and regeneration. This review thus aims to provide valuable insights for optimizing EFRB‐based therapies and to inspire further breakthroughs in this evolving field.
GLP-1 receptor agonist use and colorectal cancer risk in patients with inflammatory bowel disease.
138 Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RA’s) have advanced the treatment of type 2 diabetes mellitus (T2DM), yet their association with cancer risk remains subject of ongoing research. Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is a well-established risk factor for colorectal cancer (CRC). Studies have shown a reduced risk of CRC with GLP-1 RA use however, the impact of GLP-1 RA therapy in the high-risk IBD population is unknown. In this study, we aim to evaluate the association between GLP-1 RA use and CRC incidence among patients with IBD, and among those with IBD and T2DM. Methods: We performed a retrospective cohort study using data from TriNetX, a healthcare database of over 150 million patients in the United States. In the first analysis, adult patients with pre-existing IBD were identified and stratified by use of a GLP-1 RA (semaglutide, dulaglutide, tirzepatide, exenatide, liraglutide, and lixisenatide) or not. Propensity score matching (PSM) was conducted between GLP1-RA users and non-users, matching for age, sex, race, tobacco use, alcohol use, hypertension, hyperlipidemia, obesity, IBD subtype (CD or UC), steroid use, immunosuppressive use including biologics, and other T2DM medications. Five-year incidence of CRC was compared between GLP-1 RA users and non-users in the matched cohort between 2015 and 2025. We then restricted the cohort to patients with IBD and T2DM and repeated this analysis. Results: We identified 1,137,300 patients with IBD, including 70,303 GLP-1 RA users and 1,066,997 non-users. After PSM with all variables adequately matched, 69,221 patients were included in the analyses. GLP-1 RA use was associated with a lower 5-year incidence of CRC (0.2% vs. 0.43%, odds ratio (OR) 0.49, 95% confidence interval (CI) 0.3-0.57, p <0.001). We then identified 209,649 patients with IBD and T2DM, including 38,567 GLP-1 RA users and 171,082 non-users. After matching for all variables, 37,740 patients were included in the analyses. Among patients with IBD and T2DM, GLP-1 RA use was associated with a lower 5-year incidence of CRC (0.31% vs. 0.57%, OR 0.54, 95% CI 0.43-0.68, p <0.001). Conclusions: GLP-1 RA use was associated with a significantly reduced incidence of CRC in all patients with IBD, as well as the subpopulation with both IBD and T2DM. Given the elevated CRC risk in IBD, these findings suggest a potential protective effect of GLP-1 RA use in this high-risk population. Prospective studies will be important to further analyze and confirm this potential benefit.
Visible‐Light Unlocked Carbene Insertion and Radical Release in a Structurally Constrained Pincer Phosphorus Compound
ABSTRACT Geometrically constrained phosphines have attracted significant attention for their ability to mediate reactions traditionally associated with transition metals. Here, we show that visible‐light excitation unlocks new transition‐metal‐like reactivity in a well‐studied ONO‐pincer phosphine. Photochemical generation of α‐siloxy carbenes enables rapid P─C bond formation, affording bicyclic phosphines with complete diastereocontrol. These phosphine intermediates readily engage with electrophiles to form air‐ and moisture‐stable phosphoranes, which, upon subsequent irradiation, undergo selective P─C bond homolysis, releasing carbon‐centered radicals while regenerating the initial phosphine framework. Time‐resolved EPR spectroscopy and DFT calculations reveal that geometric constraint is crucial for accessing both carbene‐insertion rearrangement and P─C bond homolysis pathways not observed with conventional phosphines. Together, these findings establish a rare light‐driven phosphine → phosphorane →phosphine (P(III) → P(V) → P(III)) reactivity loop and demonstrate how structural constraint enables main‐group centers to perform elementary steps analogous to transition metals.
Influence of high-fat diet and sex on connective tissue in carpal tunnel syndrome
Nanomachines Based on Inner Ultrasonic Multiple Scattering for Ameliorating Renal Function
ABSTRACT Protecting cell/tissue disservice during acute kidney injury (AKI) was an important but still challenging goal. Here, we proposed a current‐ultrasound convertion‐propelled wireless positioning and tracking nanomachine in which Au covered one side of a PASP‐PArg/BaTiO 3 footplate (Au@PASP‐PArg/BaTiO 3 , ASPB). These navigational nanomaches were used in the treatment of AKI to confirm a new technology and method for actively inhibiting kidney‐trauma formation to enable highly efficient kidney‐protection. ASPB possessed the high dielectric constant and piezoelectric properties, which acquired endogenous ultrasound‐current and guided navigation under exogenous current excitement. Under the triggering of endogenous ultrasound, ASPB further gave rise to the unbalanced charges on its surface and underwent oxidation‐reduction reactions with surrounding water, obtaining H 2 O 2 and 1 O 2 ; meanwhile, ASPB could also decompose water to produce O 2 under the inducement of endogenous ultrasound. Additionally, the attained H 2 O 2 and 1 O 2 catalyzed polyarginine to discharge NO. Importantly, under accurate navigation, endogenous ultrasound‐triggered gas sensor discharged NO/O 2, and endogenous current could protect renal tissues from damage based on modulating MYDGF expressions, KCNQ1 functions, and TMAO targeted metabolomics. These current‐ultrasound convertion‐pushed navigational nanomaches clearly unveiled illustrious potential for promoting highly efficient kidney‐function protection.
Proteolysis-targeting chimera (PROTAC) to target Bruton tyrosine kinase (BTK) degradation in mantle cell lymphoma.
261 Background: Mantle cell lymphoma (MCL) is characterized by Bruton tyrosine kinase (BTK)-signaling which activates the B-cell receptor (BCR) signaling cascade. Although BTK-inhibitors are effective therapy, acquired resistance is common. Proteolysis-targeting chimera molecules (PROTACs) facilitating BTK-degradation (BTK-PROTAC) are a potential therapy. Methods: We designed 24 BTK-PROTACs and screened their activity against MCL cell lines through half maximal inhibitory concentration (IC50) assays and BTK-degradation efficiency. Effects of BTK-PROTAC on differentially expressed genes and on activation of the BCR-signaling cascade were studied by RNA-seq and molecular experiments. BTK variant cells were developed to assess the ability of BTK-PROTAC to reverse acquired BTK-inhibitor resistance in vitro assays and in mouse models. Results: Amongst BTK-PROTACs we synthesized C23 had the strongest ability to degrade BTK and inhibit proliferation of several MCL cell lines. C23 induced cell apoptosis and suppressed cancer growth by activating the ubiquitin-proteasome pathway thereby inhibiting the BCR-signaling cascade including NF-κB- and PI3K-AKT-mTOR-signaling. C23 degraded BTK inhibiting growth of BTK C481S and BTK L528W variant cells and suppressed growth of MCL cells in mouse xenograft models with BTK C481S and BTK L528W variants. Conclusions: The C23 BTK-PROTAC inhibits MCL cells with BTK variants resistant to BTK-inhibitors in vitro and in vivo models. BTK-PROTAC C23 is a potential therapy of BTK-inhibitor resistant MCL.
Dispersal mode and spatial heterogeneity shape the interaction between adaptation and dispersal in multitrophic metacommunities
Polatuzumab-R-CHP vs R-CHOP in older DLBCL: Survival benefit, infectious toxicity, and cost implications in middle-income health systems.
246 Background: Polatuzumab vedotin combined with rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) improves progression-free survival (PFS) compared with R-CHOP in diffuse large B-cell lymphoma (DLBCL). However, in older patients and in middle-income health systems, its real-world value remains uncertain because of infectious toxicity and high drug acquisition costs. We therefore aimed to synthesize comparative evidence on survival outcomes, infectious toxicity, and economic impact of Pola-R-CHP versus R-CHOP in this context. Methods: We conducted a systematic review of randomized and real-world comparative studies evaluating Pola-R-CHP versus R-CHOP in DLBCL. Random-effects meta-analyses were performed for PFS and overall survival (OS) hazard ratios (HRs) and febrile neutropenia (FN) risk ratios (RRs). Cost-effectiveness evidence was reviewed narratively from published economic models. Drug acquisition costs were estimated for Indonesia using publicly available patient access programs. Results: Across included studies, Pola-R-CHP improved PFS compared with R-CHOP (pooled HR 0.61, 95% CI 0.47 - 0.79), while OS data were immature and did not show a consistent survival advantage. FN risk estimates were heterogeneous; the primary pooled analysis did not demonstrate a statistically significant difference (RR 1.22, 95% CI 0.66–2.28). Sensitivity analysis excluding a single-center outlier suggested a possible increase in FN among older patients treated with Pola-R-CHP (RR 1.52, 95% CI 0.94–2.45). A published Italian cost-utility analysis reported modest gains of approximately 0.5 quality-adjusted life-years (QALY) with Pola-R-CHP at high income-country prices, and other health technology assessments reached similar conclusions under trial-based assumptions. In Indonesia, the estimated polatuzumab acquisition cost was approximately IDR 424 million per patient for six cycles, despite a patient access program. Conclusions: Although Pola-R-CHP provides a consistent PFS benefit, potential increase in febrile neutropenia in older patients and substantial upfront costs raise important concerns regarding its real-world value in middle-income health systems. Careful patient selection and context-specific economic evaluation are warranted. Keywords: Diffuse large B-cell lymphoma; Polatuzumab vedotin; Cost and value assessment.
The Role of Shape Commensurability in Chirality Transfer: Gold Nanoshape Solutes in a Discotic Nematic Liquid Crystal Solvent
ABSTRACT Chirality, as an inherently geometric concept, is well understood at most length scales and is a principal attribute of objects and figures. Quantitative models predicting the efficacy of chirality transmission across length scales have only recently begun to emerge. We provide further proof‐of‐concept data and calculations for a modus operandi for nanoshape solutes featuring a chiral ligand shell in an achiral discotic nematic (ND) liquid crystal solvent, demonstrating that chirality transfer can be understood through remarkably simple geometric considerations. This mechanism is based on the product of a pseudoscalar chirality indicator and a geometric shape compatibility factor based on the 2D isoperimetric quotients for nanoshape solutes and N D molecule. The model is tested on an experimental set of precisely engineered gold nanoshapes, rods, prisms, and discs, that validates that shape commensurability between nanoscale solute and nematic solvent is a prerequisite for efficacious chirality transfer as determined by the helical twisting power of the nanoshapes in the induced chiral N D * phase. Thus, we predict that libraries of calculated and in‐parallel acquired experimental data among related nanoshapes and even small organic molecules pave the way for predictive calculations of chirality transfer in nanoscale, macromolecular, biological, and small‐molecule systems.
Evolution of network structure and driving mechanisms of food production resilience in arid regions: a machine learning-based approach
Stabilization of Unconventional Body‐Centered Tetragonal Phase in Copper Nanowires for Efficient Carbon Dioxide Electroreduction to Multi‐Carbon Products
ABSTRACT Copper nanomaterials with the common face‐centered cubic (fcc) phase have been widely used in the electrocatalytic carbon dioxide (CO 2 ) reduction reaction (CO 2 RR). However, copper with an unconventional phase is rarely reported as it is thermodynamically unfavorable. Here, through analyzing the strain within copper nanowires, we reveal the phase transition of copper from fcc to body‐centered tetragonal (bct)/fcc heterophase. By systematically investigating copper nanowires with different diameters and copper nanocubes in CO 2 RR, we explain the relationship between their crystal phase and catalytic performance. Compared with the standard fcc lattice, copper nanowires’ surfaces have different electron states due to a phase transition. Copper nanowires with a diameter of about 30 nm exhibit the optimum catalytic performance, and their Faradaic efficiency of multi‐carbon products is much higher than that of fcc copper nanocubes. Theoretical calculations have demonstrated that the presence of the strained bct phase induces significant upshifts of the d ‐band center, which not only improves the overall electroactivity but also optimize the C‐C couplings, leading to improved Faradaic efficiency of multi‐carbon products during CO 2 RR.